📰 Functional Outcomes News
Page 3 - Functional Outcomes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Functional Outcomes. Real-time updates on events, politics, business and more.
October 20, 2022
Japan: Researchers have found in a new study that Endovascular therapy is effective in less severe acute large vessel occlusive stroke with ASPECTS 4 to 5.In patients with ASPECTS 3 or less,...
August 18, 2022
Renee Kinder Tuesday evening, I began the painful eye roll-inducing process of organizing and sorting school supplies for our official start today.
March 25, 2022
Maximally sustaining IL-6 suppression in a chronic disease like NMOSD and enabling subcutaneous dosing every four weeks. Positive Phase III results for ENSPRYNG, as both monotherapy and in... | March 25, 2022
March 25, 2022
First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue
March 23, 2022
Among patients with large vessel occlusion acute ischemic stroke and successful reperfusion following thrombectomy, the use of adjunct intra-arterial alteplase was effective, according to a recent...
March 7, 2022
Dr Elizabeth England, GP and clinical advisor for mental health for the RCGP, and Dr Tony Lloyd, CEO of the ADHD Foundation, discuss the impact of unrecognised ADHD in adults on primary care and the urgent need to increase the provision of specialist services.
January 17, 2022
Aims: To determine associations between frailty and patient outcomes for participants in an acute rehabilitation program. Methods: Retrospective participant data (n = 987) was extracted, and correlations between the Clinical Frailty Scale (CFS) and patient outcomes (FIMTM, FIMTM Efficiency, LOS, Discharge Destination, Unexpected clinical complication) were examined through statistical analysis (Logistic regression, ANCOVA, Kendall’s Tau, odds ratios). Results: The study cohort was 49.1% female...
January 5, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive data from the Phase 3 multicenter, placebo-controlled, double-blind,...
January 5, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive data from the Phase 3 multicenter, placebo-controlled, double-blind,...
January 5, 2022
Treatment with Xywav resulted in clinically meaningful improvement in idiopathic hypersomnia symptoms, including excessive daytime sleepiness, sleep inertia and prolonged sleep duration with